These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32783025)

  • 1. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia.
    Pech O; Alqahtani SA
    Ther Adv Gastrointest Endosc; 2020; 13():2631774520935241. PubMed ID: 32783025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?
    Singh T; Sanaka MR; Thota PN
    World J Gastrointest Endosc; 2018 Sep; 10(9):165-174. PubMed ID: 30283599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic eradication therapy for Barrett's oesophagus: state of the art.
    Kolb JM; Wani S
    Curr Opin Gastroenterol; 2020 Jul; 36(4):351-358. PubMed ID: 32487852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic Management of Dysplastic Barrett's Oesophagus and Early Oesophageal Adenocarcinoma.
    Eusebi LH; Telese A; Castellana C; Engin RM; Norton B; Papaefthymiou A; Zagari RM; Haidry R
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic management of dysplasia and early oesophageal cancer.
    Zeki SS; Bergman JJ; Dunn JM
    Best Pract Res Clin Gastroenterol; 2018; 36-37():27-36. PubMed ID: 30551853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
    Pech O
    Adv Exp Med Biol; 2016; 908():99-109. PubMed ID: 27573769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art management of dysplastic Barrett's esophagus.
    Vantanasiri K; Iyer PG
    Gastroenterol Rep (Oxf); 2022; 10():goac068. PubMed ID: 36381221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's oesophagus: new diagnostic and therapeutic techniques.
    Haringsma J
    Scand J Gastroenterol Suppl; 2002; (236):9-14. PubMed ID: 12408497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus.
    Bureo Gonzalez A; Bergman JJ; Pouw RE
    United European Gastroenterol J; 2016 Oct; 4(5):657-662. PubMed ID: 27733907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
    Belghazi K; Bergman JJGHM; Pouw RE
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic therapy for Barrett's oesophagus.
    Blevins CH; Iyer PG
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):167-77. PubMed ID: 25743464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
    Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dysplastic Barrett's Oesophagus in lower volume centres after structured training.
    Chadwick G; Faulkner J; Ley-Greaves R; Vlavianos P; Goldin R; Hoare J
    World J Gastrointest Endosc; 2015 Jan; 7(1):66-72. PubMed ID: 25610536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review.
    Luigiano C; Iabichino G; Eusebi LH; Arena M; Consolo P; Morace C; Opocher E; Mangiavillano B
    Gastroenterol Res Pract; 2016; 2016():4249510. PubMed ID: 28070182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection.
    Anders M; Bähr C; El-Masry MA; Marx AH; Koch M; Seewald S; Schachschal G; Adler A; Soehendra N; Izbicki J; Neuhaus P; Pohl H; Rösch T
    Gut; 2014 Oct; 63(10):1535-43. PubMed ID: 24389236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.